Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hodgkin Disease × Irinotecan × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Pancreatic Neoplasms 15 Neuroblastoma 9 Neoplasm Metastasis 9 Colonic Neoplasms 7 Stomach Neoplasms 6 Sarcoma, Ewing 6 Rhabdomyosarcoma 5 Rectal Neoplasms 5 Neoplasms 5 Medulloblastoma 4 Esophageal Squamous Cell Carcinoma 4 Sarcoma 3 Recurrence 3 Ovarian Neoplasms 3 Osteosarcoma 3 Esophageal Neoplasms 3 Ependymoma 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Fibrolamellar hepatocellular carcinoma 2 Colorectal Adenocarcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

Cyclophosphamide 11 pembrolizumab 7 fludarabine 7 fludarabine phosphate 6 Doxorubicin 6 Vinblastine 5 Gemcitabine 5 Filgrastim 5 Dacarbazine 5 Brentuximab Vedotin 5 Bleomycin 5 Nivolumab 4 Mycophenolic Acid 4 Magnetic Resonance Spectroscopy 4 Granulocyte Colony-Stimulating Factor 4 Etoposide 4 Vincristine 3 Rituximab 3 Prednisone 3 Melphalan 3 Cisplatin 3 pegfilgrastim 2 Whole-Body Irradiation 2 Vinorelbine 2 Thiotepa 2 Tacrolimus 2 Specimen Handling 2 Radiotherapy 2 Prednisolone 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡